SHIMIZU Shoichi

School of Medicine Department of MedicineAssistant Professor

Researcher Information

Field Of Study

  • Life sciences, Fetal medicine/Pediatrics
Research activity information

Paper

  • Body fat-reducing effects of whey protein diet in male mice.
    Nakazaki K; Nagano N; Katayama D; Shimizu S; Matsuda K; Tokunaga W; Aoki R; Fuwa K; Morioka I
    Nutrients, 2023
  • 持続可能な山岳診療のための方策と課題 山岳診療所を100年企業とするために
    原田智紀; 清水翔一; 平林幸生
    登山医学, 2022
  • COVID-19蔓延下の山岳診療の現状と課題 COVID-19蔓延下での日本大学医学部徳沢診療所の現状と課題
    清水翔一; 原田智紀
    登山医学, 2022
  • A neonate with interstitial pneumonia due to human metapneumovirus infection.
    Tanaka Y; Shimizu S; Namiki H; Morohashi T; Morioka I
    Pediatrics International, 2022
  • Successful treatment with anti-C5 monoclonal antibody in a Japanese adolescent who developed thrombotic microangiopathy after autologous bone marrow transplantation for malignant lymphoma.
    Shimizu S; Morohashi T; Kanezawa K; Yagasaki H; Takahashi S; Morioka I
    Frontiers in Pediatrics, 2022
  • A non-obese hyperglycemic mouse model that develops after birth with low birthweight.
    Katayama D; Nagano N; Shimizu S; Nakazaki K; Matsuda K; Tokunaga W; Fuwa K; Aoki R; Morioka I
    Biomedicines, 2022
  • b2-microglobulin measurement with dried urine spots for congenital anomalies of the kidney and urinary tract screening in 3-year-old children.
    Morohashi T, Wada N, Odaira S, Shimizu S, Takahashi S, Morioka I
    Pediatrics International, 2022
  • Severe olfactory and gustatory dysfunctions in a Japanese pediatric patient with coronavirus disease (COVID-19).
    Kasuga Y; Nishimura K; Go H; Nakazaki K; Go H; Shimizu S; Kanezawa K; Tanaka M; Oshima T; Morioka I
    Journal of Infection and Chemotherapy, 2021
  • 新型コロナウイルス検査を行った小児の臨床背景:単独施設における検討.
    大澤大和; 春日悠岐; 呉英俊; 中﨑公隆; 清水翔一; 西村光司; 金澤剛二; 森岡一朗
    小児感染免疫, 2021
  • Characteristics of Kawasaki disease patients during the COVID-19 pandemic in Japan: A single-center observational study.
    23.Shimizu S; Ayusawa M; Go H; Nakazaki K; Namiki H; Kasuga Y; Nishimura K; Kanezawa K; Morohashi T; Morioka I
    Children, 2021
  • IgA nephropathy in a patient with an MYH9-related disorder.
    Shimizu S; Morohashi T; Takahashi Y; Takahashi S; Morioka I
    Pediatrics Internationa, 2021
  • What is the difference in severity of pediatric coronavirus disease 2019?
    Kasuga Y; Kanezawa K; Shimizu S; Nakazaki K; Go H; Nishimura K; Morioka I
    Acta Paediatrica., 2021
  • Role of complement 3 in renin generation during the differentiation of mesenchymal stem cells to smooth muscle cells.
    Chen L; Fukuda N; Shimizu S; Kobayashi H; Tanaka S; Nakamura Y; Matsumoto T; Abe M
    American Journal of Physiology - Cell Physiology, 2020
  • What is the difference in severity of paediatric coronavirus disease 2019?
    Kasuga Y; Kanezawa K; Shimizu S; Nakazaki K; Go H; Nishimura K; Morioka I
    Acta Paediatrica, 2020
  • 著明な片側腎機能低下を認めたが腎瘻設置で腎摘を回避できた水腎症の1例.
    中崎公隆,清水翔一,諸橋 環,河村研吾,高橋昌里,森岡一朗
    日本小児腎臓病学会雑誌, 2020
  • 学校検尿を契機に発見されたTubulointerstitial nephritis and uveitis syndrome の1例.
    清水翔一,諸橋環,高橋昌里,森岡一朗
    日本小児腎不全学会雑誌, 2020
  • 【症候・疾患からみる小児の検査】 症候からみる臨床検査の進めかた 蛋白尿 (血尿を伴わない).
    清水翔一,高橋昌里
    小児科診療, 2020

Research Themes

  • 低出生体重仔の成獣期高血圧・慢性腎臓病発症機序の解明とタウリンによる予防効果
    日本学術振興会, 科学研究費助成事業, 01 Apr. 2022 - 31 Mar. 2024
    清水 翔一